Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
18.00
+0.17 (0.95%)
Nov 24, 2025, 4:00 PM EST - Market closed
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $326.41 million as of November 25, 2025. Its market cap has increased by 2,248.28% in one year.
Market Cap
326.41M
Enterprise Value
215.35M
1-Year Change
2,248.28%
Ranking
Category
Stock Price
$18.00
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $326.41M, an increase of 846.12%. That is a compound annual growth rate of 25.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 323.30M | 318.78% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |